Trial
NCT02455167
Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
Janssen Scientific Affairs, LLC
Condition
Hepatitis C
Intervention
Simeprivir (SMV)
Why stopped
Study stopped due to low accrual and availability of other treatment options
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-13